 Recipients of the Frost & Sullivan 2008 North American Pharmaceuticals & Biotechnology Emerging Markets Healthcare Innovation Award, our patented technology is at the forefront of product innovation through its ability to preserve, regenerate and culture cell in the absence of animal based components. This highly innovative technology has been successful in preserving solid organ, heart, limbs and skin cells at room temperature, regenerate rejected human kidney for transplantation, cryopreserve vaccine cells and equine stem cells without the use of DMSO and culture cancer cells and vaccine cells without the use of fetal bovine serum. The Company draws upon its proprietary patented technology to address some of the world’s most pressing issues in the fields of organ preservation, regenerative medicine and cell therapy. Lifeblood Medical, Inc.’s vision is to continue to develop novel solutions through our ability to preserve every cell in the human body.
Lifeblood values and actively seeks collaborative relationships with organizations that share our commitment to advancing the fields of organ preservation, regenerative medicine and cell therapy. Please contact us at collaborations@lifebloodmedical.com to learn more about potential opportunities. |
